D-0635-2020 Class III Terminated

Recalled by Lupin Pharmaceuticals Inc. — Baltimore, MD

FDA drug recall D-0635-2020 was initiated by Lupin Pharmaceuticals Inc. on Dec 13, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity. The recall status is terminated (terminated Oct 19, 2020). Affected quantity: 2,130 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 8, 2020
Initiation Date
Dec 13, 2019
Termination Date
Oct 19, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,130 bottles

Product description

Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL bottle, Manufactured by: Lupin Limited, Pithampur (M.P.), INDIA, NDC: 68180-429-03.

Reason for recall

Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other individual impurity.

Distribution pattern

Nationwide in the U.S.

Code information

Lot# H801686, Exp. 12/31/2019.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0635-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0635-2020. Report a data issue: hello@regdatalab.com.